SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 53 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $94,000 | -62.5% | 108,010 | 0.0% | 0.02% | -63.9% |
| Q1 2019 | $251,000 | 0.0% | 108,010 | 0.0% | 0.06% | -11.6% |
| Q4 2018 | $251,000 | -84.3% | 108,010 | 0.0% | 0.07% | -80.9% |
| Q3 2018 | $1,601,000 | -8.7% | 108,010 | -6.4% | 0.36% | -11.1% |
| Q2 2018 | $1,753,000 | -19.0% | 115,420 | +1.3% | 0.41% | -20.1% |
| Q1 2018 | $2,163,000 | – | 113,917 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|